Summary
Latest filing:
Valerie Odegard files SEC Form 4 reports at Odyssey Therapeutics, Inc. (ODTX). 1 SEC Form 4 filing on record, dated 12 May 2026.
Trading pattern
InsiderAlpha's records for Valerie Odegard go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Valerie Odegard files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- TPG GP A, LLC - $25.00M in ODTX purchases and sales in the last 12 months
- Nan (Ln) Li - $20.00M in ODTX purchases and sales in the last 12 months
- Dimension Capital II, L.P. - $20.00M in ODTX purchases and sales in the last 12 months
- SR ONE CAPITAL MANAGEMENT, LLC - $10.03M in ODTX purchases and sales in the last 12 months
- Shelley Chu - $200K in ODTX purchases and sales in the last 12 months
- Jeffrey M. Leiden - $100K in ODTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Valerie Odegard?
Valerie Odegard is a corporate insider of Odyssey Therapeutics, Inc. (ODTX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Valerie Odegard last file a Form 4?
The only primary Form 4 on record is dated 12 May 2026.